<?xml version="1.0" encoding="UTF-8"?>
<p>It has always been true that drug discovery and development (DD&amp;D) depend on the skills of many different disciplines. However, the best combination of skills may be found in different institutions, each being critical to different parts of the DD&amp;D pipeline. To illustrate the potential advantages and pitfalls associated with collaborations, Maaike chose two examples, the Alabama Drug Discovery Alliance (ADDA) and the Antiviral Drug Discovery and Development Consortium (AD3C).</p>
